Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Methods Enzymol. 2012;508:109-30. doi: 10.1016/B978-0-12-391860-4.00006-9.

Multistage nanoparticles for improved delivery into tumor tissue.

Author information

  • 1Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.

Abstract

The enhanced permeability and retention (EPR) effect has been a key rationale for the development of nanoscale carriers to solid tumors. As a consequence of EPR, nanotherapeutics are expected to improve drug and detection probe delivery, have less adverse effects than conventional chemotherapy, and thus result in improved detection and treatment of tumors. Physiological barriers posed by the abnormal tumor microenvironment, however, can hinder the homogeneous delivery of nanomedicine in amounts sufficient to eradicate cancer. To effectively enhance the therapeutic outcome of cancer patients by nanotherapeutics, we have to find ways to overcome these barriers. One possibility is to exploit the abnormal tumor microenvironment for selective and improved delivery of therapeutic agents to tumors. Recently, we proposed a multistage nanoparticle delivery system as a potential means to enable uniform delivery throughout the tumor and improve the efficacy of anticancer therapy. Here, we describe the synthesis of a novel multistage nanoparticle formulation that shrinks in size once it enters the tumor interstitial space to optimize the delivery to tumors as well as within tumors. Finally, we provide detailed experimental methods for the characterization of such nanoparticles.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22449923
[PubMed - indexed for MEDLINE]
PMCID:
PMC3774840
Free PMC Article

Images from this publication.See all images (5)Free text

Figure 6.1
Figure 6.2
Figure 6.3
Figure 6.4
Figure 6.5
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk